A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

Clinical trial NCT02103283 · COMPLETED

Trial details

NCT number: NCT02103283
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2014-10-01
Primary completion: 2016-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.